European Union - English - EMA (European Medicines Agency)

ammtek - glibenclamide - diabetes mellitus - drugs used in diabetes - amglidia is indicated for the treatment of neonatal diabetes mellitus, for use in newborns, infants and children.sulphonylureas like amglidia have been shown to be effective in patients with mutations in the genes coding for the β-cell atp-sensitive potassium channel and chromosome 6q24-related transient neonatal diabetes mellitus.

Israel - English - Ministry of Health

dexcel ltd, israel - glibenclamide - tablets - glibenclamide 5 mg - glibenclamide - glibenclamide - control of hyperglycemia in stable, mild, nonketosis prone glibenclamide responsive type ii diabetes mellitus, which cannot be controlled by proper dietary management or when insulin therapy is inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg; glibenclamide, quantity: 5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; quinoline yellow; iron oxide yellow; iron oxide red; macrogol 4000 - second line treatment of diabetes mellitus type ii in adult patients whose glycaemic control is inadequate after diet and exercise alone and where combined therapy with metformin and glibenclamide is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg; glibenclamide, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - second line treatment of diabetes mellitus type ii in adult patients whose glycaemic control is inadequate after diet and exercise alone and where combined therapy with metformin and glibenclamide is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 250 mg; glibenclamide, quantity: 1.25 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - second line treatment of diabetes mellitus type ii in adult patients whose glycaemic control is inadequate after diet and exercise alone and where combined therapy with metformin and glibenclamide is appropriate.

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - glibenclamide - tablets - milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

origen pharmaceuticals limited - glibenclamide 5mg - tablet - 5 mg - active: glibenclamide 5mg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sanwa kagaku kenkyusho co.,ltd. - glibenclamide - white tablet, with a split line, diameter: 6.0 mm, thickness: 1.9 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - glibenclamide - white tablet, diameter: 6.0 mm, thickness: 1.9 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sanwa kagaku kenkyusho co.,ltd. - glibenclamide - white tablet, with a split line, major axis: 8.1 mm, minor axis: 4.1 mm, thickness: 2.3 mm